CM
TXG icon

Caption Management’s 10x Genomics TXG Stock Holding History

Caption Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,000
Closed -$67.7K – 1836
2024
Q3 		$67.7K Buy
+3,000
New +$62K ﹤0.01% 1152
2022
Q2 		– Sell
-3,500
Closed -$265K – 1842
2022
Q1 		$265K Buy
+3,500
New +$306K ﹤0.01% 1236

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caption Management's TXG Position: Q4 2024 in Review

Caption Management sold out of 10x Genomics (TXG) in Q4 2024, closing a stake of 3,000 shares — an estimated $67.7K sold.

Caption Management first reported a position in TXG in Q1 2022 and held it in 2 quarters. The position peaked at $265K in Q1 2022. 273 funds tracked by Wall St. Rank hold TXG as of Q4 2024.

  • Caption Management reported no remaining 10x Genomics position as of Q4 2024 after selling out during the quarter.
  • Caption Management sold 3,000 10x Genomics shares in Q4 2024, an estimated $67.7K.
  • Caption Management first reported a position in 10x Genomics in Q1 2022 and held it in 2 quarters.
  • Caption Management's 10x Genomics position peaked at $265K in Q1 2022.
  • 273 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2024.

Based on Caption Management's 13F filing for Q4 2024, filed 14 Feb 2025.